Evidence map›Paper›PMID 41192423›Full record

ArticleCell2025

Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic states.

Nikolai P Jaschke, Joseph R Luchsinger, Zuojia Chen, Vera C Wulfmeyer, Xavier de la Rosa, Oliver Hahn, Cuiling Zhang, Nathaniel D Bachtel, Jaime L Cullen, Tilman D Rachner and 4 more

Abstract read
In one paragraph

Article in Cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Vitamin D is glucoprotective in aging males but not females.The Journal of steroid biochemistry and molecular biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nikolai P JaschkeDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Department of Internal Medicine (Rheumatology, Allergy, and Immunology), Yale School of Medicine, New Haven, CT 06510, USA; Department of Medicine I & III, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Translational Immunology, Hamburg, Germany. Electronic address: nikolai.jaschke@yale.edu.
Joseph R LuchsingerDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA.
Zuojia ChenExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Vera C WulfmeyerDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Xavier de la RosaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Oliver HahnDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Cuiling ZhangDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.
Nathaniel D BachtelDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.
Jaime L CullenDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.
Tilman D RachnerDepartment of Medicine III, University Hospital Dresden, Dresden, Germany.
Ruslan MedzhitovDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Tananbaum Center for Theoretical and Analytical Human Biology, Yale University School of Medicine, New Haven, CT, USA.
Markus M RinschenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Medicine III & Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chuan WuExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
Andrew WangDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Department of Internal Medicine (Rheumatology, Allergy, and Immunology), Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: andrew.wang@yale.edu.

Funding

RESEARCH TRAINING - BIOLOGICAL SCIENCEST32MH014276 · NIMH · YALE UNIVERSITY · PI Marina R Picciotto · 1985 to 2026
$7.2M
Clinical Neuroscience Research Training Program in PsychiatryT32MH019961 · NIMH · YALE UNIVERSITY · PI Christopher John Pittenger · 1996 to 2026
$5.9M
Schizophrenia Research FellowshipR25MH071584 · NIMH · YALE UNIVERSITY · PI Christopher John Pittenger · 2005 to 2026
$4.4M
Dissecting How Xenobiotics Act as Adjuvants for Oral Allergic SensitizationR01AI162645 · NIAID · YALE UNIVERSITY · PI Andrew Wang · 2021 to 2026
$3.6M
The Role of the Adrb3/IL6 Axis in the Impact of Psychosocial Stress on Lupus PathogenesisR01AR080104 · NIAMS · YALE UNIVERSITY · PI Andrew Wang · 2022 to 2026
$2.2M
Immune-neuron crosstalk regulates intestinal homeostasisZIABC012034 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WU, CHUAN · 2021 to 2025
$2.0M
Mast cell regulation of food allergen induced malaise through GDF15-GFRAL signalingF30AI174787 · NIAID · YALE UNIVERSITY · PI BACHTEL, NATHANIEL DALE · 2023 to 2025
$121k
Intramural NIH HHS ZIA BC012034NIAID NIH HHS F30 AI174787NIAID NIH HHS R01 AI162645NIAMS NIH HHS R01 AR080104NIMH NIH HHS R25 MH071584NIMH NIH HHS T32 MH014276NIMH NIH HHS T32 MH019961
6 · The paper itself

Abstract

Dietary needs are dynamic, with optimal ranges for nutrients varying over time and across physiological states. How optimal nutrient set points are established and why they are adjusted remains largely unknown. In our efforts to understand the physiology of recovery, we made the surprising observation that mice restrict protein intake at the expense of caloric supply. We identified three amino acids-glutamine (Q), lysine (K), and threonine (T)-within dietary protein, which are necessary and sufficient for protein aversion during recovery from catabolic states. The anorexigenic effects of QKT are driven by ammoniagenesis in the gut, sensed by enterochromaffin cells in a TRPA1-dependent fashion and transduced to brainstem neurons via serotonin signaling, inducing anorexia. We propose that this mechanism serves as a first-line defense against ammonia toxicity. In summary, we identified a set of adaptive food preferences during recovery ("recovery behavior"), with implications for understanding diseases of pathologic recovery and the development of therapeutic interventions deployed to enhance recovery.

Indexed as

BrainDietary ProteinsGastrointestinal TractAmino AcidsAnimalsGlutamineLysineMaleMiceMice, Inbred C57BLNeuronsSerotoninSignal TransductionTRPA1 Cation ChannelAmino AcidsDietary ProteinsGlutamineLysineSerotoninTRPA1 Cation Channelamino acidsammoniadietary proteingut-brain axishigh protein dietprotein leveragerecoveryTRPA1urea cycle

Identifiers

PMID41192423
PMCPMC12766652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.